Related Experiment Video
Updated: Dec 4, 2025
07:05
Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer
Published on: September 22, 2015
10.4K
3D Bioprinting: The Roller Coaster Ride to Commercialization
Anton Elemoso1, Grigoriy Shalunov1, Yakov M Balakhovsky2
1Laboratory of Biotechnical Research 3D Bioprinting Solutions, Moscow, Russian Federation.
International Journal of Bioprinting
|October 22, 2020
Summary
Three-dimensional (3D) bioprinting offers vast potential in regenerative medicine, drug discovery, and food industries. Despite nearly two decades of research, commercial applications remain limited, with challenges hindering widespread adoption.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Biofabrication
Background:
- Three-dimensional (3D) bioprinting, encompassing technologies like inkjet, extrusion, and laser, has been researched since 2003.
- Despite its versatility and potential, commercial applications remain limited after almost 20 years.
Purpose of the Study:
- To discuss the potential of 3D bioprinting in regenerative medicine, drug discovery, and the food industry.
- To highlight existing commercialized products and services, including those in fashion.
- To analyze go-to-market strategies and financing for 3D bioprinting companies.
Main Methods:
- Review of existing literature and case studies on 3D bioprinting technologies.
- Analysis of commercial applications across various industries.
- Identification of barriers to practical implementation.
Main Results:
- Identified key areas of potential for 3D bioprinting: regenerative medicine, drug discovery, food, and fashion.
- Documented companies with commercialized 3D bioprinting products and services.
- Outlined go-to-market routes and financing models.
Conclusions:
- 3D bioprinting holds significant promise across multiple sectors, yet faces challenges in commercialization.
- Addressing identified barriers is crucial for unlocking the technology's full potential and driving market adoption.
